Similarly, across 29 breast cancer cells exposed to ENMD-2076, a dual Aurora and angiogenesis-involved kinase inhibitor with higher selectivity to AURKA, showed significant growth inhibition and senescence induction activity across TNBC cell lines at lower concentrations as opposed to ER or Her2-positive cell lines. Here, AURKA is linked to breast cancer.